TABLE 5

Drug radioequivalent concentrations (microgram equivalents per gram) in tissues of Long-Evans male and female rats administered an oral dose (13.8 mg/kg) of [14C]LAS

The LLOQ was 0.6 μg Eq/g.


Tissue

1 h

3 h

8 h

12 h

168 h
M
F
M
F
M
F
M
F
M
F
Adipose: brown 5.6 6.3 4.0 3.8 2.2 1.7 a
Adrenal gland 24 N.D. 13 11 6.4 4.1
Blood: systemic 1.7 1.2 0.8
Bone marrow 7.1 5.8 4.6 4.4 3.3 2.5
Contents: gastric 572 490 288 320 124
Contents: intestinal 261 313 320 375 231 79 48 22 3.4
CNS tissuesb 1.8 1.6 1.2 0.9 0.7 0.7
Kidney 8.6 8.3 6.7 4.9 2.3 1.5 0.9
Lacrimal gland 8.2 6.3 11 8.5 20 19 16 15
Liver 23 27 20 16 6.7 4.6 3.2 2.1
Lung 21 16 14 16 6.8 10 2.8 1.6
Myocardium 7.1 6.0 4.4 3.4 1.5 1.1
Pancreas 16 15 15 12 N.D. 6.0 2.5 2.1
Salivary gland 11 8.8 9.2 8.0 6.5 7.5 0.9
Skeletal muscle 2.5 2.6 2.3 1.7 0.9
Spleen 17 16 11 8.7 4.5 4.1 1.5 0.9
Testis or ovary 0.8 8.5 1.0 N.D. 1.8 2.7 1.8
Thymus 4.0 3.8 3.8 3.0 2.7 2.5 0.9 0.7
Uvea 12 8.8 12 10 21 15 14 13 7.1 4.6
Whole-body
16
22
15
24
18
10
6.0
2.4


  • M, male; F, female; N.D., sample was not obtained at this time point.

  • a Tissue [14C]LAS radioequivalents either declined below the LLOQ, or the tissue was indistinguishable from background (—).

  • b Noncircumventricular central nervous system (CNS) tissues (e.g. cerebellum, cerebrum, medulla oblongata, mesencephalon, olfactory bulb, and pons) were collectively assessed for [14C]LAS radioequivalent concentrations due to the low amounts of distributed radioactivity into the brain.